ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "Mitochondrial Dysfunction"

  • Abstract Number: 1266 • ACR Convergence 2024

    Anti-Mitochondrial Antibodies Associate with Disease Activity and IFNα Expression in Childhood-onset Systemic Lupus Erythematosus

    Marina Barguil Macedo1, Javad Wahadat2, Albin Bjoerk3, Sylvia Kamphuis2, Marjan Versnel2 and Christian Lood1, 1University of Washington, Seattle, WA, 2Erasmus University Medical Center, Rotterdam, Netherlands, 3Karolinska Institutet, Stockholm, Sweden

    Background/Purpose: Extracellular mitochondria may represent a source of antigenic burden in autoimmune disorders, such as in systemic lupus erythematosus (SLE), in which those organelles, released…
  • Abstract Number: 1684 • ACR Convergence 2024

    Autoantibodies to Transcription Factor a Mitochondria Are Associated with Damage Accrual, Malignancy Risk and Mortality in SLE

    Eduardo Gomez1, Daniel Goldman2, Merlin Paz3, Michelle Petri2 and Felipe Andrade4, 1The Johns Hopkins University, Baltimore, MD, 2Johns Hopkins University School of Medicine, Timonium, MD, 3Johns Hopkins Medicine, Baltimore, MD, 4The Johns Hopkins University School of Medicine, Timonium, MD

    Background/Purpose: We recently identified autoantibodies in SLE that target transcription factor A mitochondrial (TFAM), a critical protein in mitochondrial DNA transcription and packaging1. These autoantibodies…
  • Abstract Number: 1735 • ACR Convergence 2024

    High-Intensity Interval Training Outperforms Moderate Exercise in Aerobic Capacity for Recent-Onset Idiopathic Inflammatory Myopathies: A Randomized Controlled Trial

    Kristofer Andreasson1, Cecilia Leijding1, Maryam Dastmalchi2, Antonella Notarnicola3, Stefano Gastaldello1, Heléne Sandlund2, Daniel Andersson4, Ingrid Lundberg5 and Helene Alexanderson2, 1Karolinska Institutet, Stockholm, Sweden, 2Karolinska University hospital, Stockholm, Sweden, 3Karolinska University Hospital and Karolinska Institutet, Stockholm, Stockholms Lan, Sweden, 4Karolinska Institutet, Solna, Sweden, 5Karolinska Universitetssjukhuset, Karolinska Institutet, Stockholm, Sweden

    Background/Purpose: Exercise is a recognized adjunctive therapy for patients with idiopathic inflammatory myopathies (IIM), enhancing physical capacity and reducing inflammation. Hitherto, moderate-to-intensive exercise has been…
  • Abstract Number: 1783 • ACR Convergence 2024

    Deciphering the Roles of Mitochondrial-Related Genes and Ferroptosis in Systemic Lupus Erythematosus: Integrated Analysis for Diagnostic Biomarker Identification and Therapeutic Insights

    Yunfeng Dai and Zhihan Chen, Fujian Medical University, Fuzhou City, Fujian, China (People's Republic)

    Background/Purpose: Systemic lupus erythematosus (SLE) is a complex autoimmune disease with heterogeneous clinical manifestations. Understanding the molecular mechanisms of SLE is crucial for developing effective…
  • Abstract Number: 2036 • ACR Convergence 2024

    CCN6 Gene Mutation Induces Mitochondrial Dysfunction: The Cause of Progressive Pseudo-rheumatoid Dysplasia

    Yanhong Li1, Xiufeng Bai2 and Yi Liu3, 1West China School of Medicine and West China Hospital, Sichuan University, Cheng Du, Sichuan, China, 2West China Hospital, Sichuan University, Chengdu, Sichuan, China (People's Republic), 3West China Hospital of Sichuan University, Chengdu, Sichuan, China

    Background/Purpose: Progressive pseudo-rheumatoid dysplasia (PPRD) is a rare autosomal recessive disorder characterized by non-inflammatory joint issues that primarily affect the articular cartilage. This leads to…
  • Abstract Number: 2298 • ACR Convergence 2024

    Fibroblast-driven Ttek Activation May Drive Acinar Cell Dysfunction in Sjögren’s Disease, Prior to Lymphocytic Infiltration

    Ting Yang1, Rick Wilbrink1, Janneke Terpstra1, Silvia Liefers2, Arjan Vissink1, Fred Spijkervet1, Hendrika Bootsma3, Frans Kroese4 and Sarah Pringle4, 1UMCG, Groningen, Netherlands, 2University Medical Center Groningen, University of Groningen, Groningen, Groningen, Netherlands, 3Department of Rheumatology and Clinical Immunology, University of Groningen, University Medical Center Groningen, Groningen, Groningen, Netherlands, 4University Medical Center Groningen, Groningen, Netherlands

    Background/Purpose: Lymphocytic infiltration of the salivary glands (SGs) represents one hallmark of the autoimmune conditions Sjögren’s Disease (SjD). It is becoming apparent however that loss…
  • Abstract Number: 2670 • ACR Convergence 2024

    Sera from Patients with Idiopathic Inflammatory Myopathy Induces Muscle Weakness, Mitochondrial Dysfunction and Induction of Cytokines in Isolated Skeletal Muscle

    Cecilia Leijding1, Suchada Kaewin2, Kristofer Andreasson1, Tomas Schiffer1, Angeles Galindo-Feria3, Begum Horuluoglu1, Mattias Carlstrom1, Stefano Gastaldello1, Helene Alexanderson4, Ingrid Lundberg5 and Daniel Andersson6, 1Karolinska Institutet, Stockholm, Sweden, 2Karolinska Institutet, Stockholm, 3Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden, 4Karolinska University Hospital, Stockholm, Sweden, 5Karolinska Universitetssjukhuset, Karolinska Institutet, Stockholm, Sweden, 6Karolinska Institutet, Solna, Sweden

    Background/Purpose: Idiopathic inflammatory myopathies (IIM) are a group of systemic autoimmune inflammatory muscle disorders characterized by symmetrical skeletal muscle weakness and accelerated fatigue. Although signs…
  • Abstract Number: 1141 • ACR Convergence 2024

    Defining a Novel Type of Myositis: Immune Mediated Megaconial Myopathy (IMMM)

    Teerin Liewluck1, Ashley Santilli2, Oliver Ni3, Margherita Milone2, Duygu Selcen2, Anahit Mehrabyan4, Arjun Seth5, Christine Hsieh5, Wasim Raslan6, Moayd Alkhalifah6, Raed Alenezi6, Stefan Nicolau7 and Pannathat Soontrapa8, 1Mayo Clinic, Rochester, MN, 2Mayo Clinic-Rochester, Rochester, MN, 3Hennepin Healthcare, Minneapolis, MN, 4University of North Carolina, Chapel Hill, NC, 5Northwestern University, Chicago, IL, 6Johns Hopkins Aramco Healthcare, Dhahran, Saudi Arabia, 7Nationwide Children’s Hospital, Columbus, OH, 8Siriraj Hospital, Mahidol University, Bangkok, Thailand

    Background/Purpose: To describe a novel type of myositis, immune mediated megaconial myopathy (IMMM),  pathologically characterized by giant mitochondria (megaconia).Methods: We reviewed the Mayo Clinic Muscle…
  • Abstract Number: 0066 • ACR Convergence 2023

    Mitochondrial Dysfunction and Fatigue in Sjögren’s Disease

    Biji T Kurien1, Rebecca Wood2, Gavin Pharaoh3, Joshua Cavett1, Valerie Lewis1, Bhaskaran Shylesh1, Lida radfar1, Astrid Rasmussen1, Christopher Lessard1, A. Darise Farris1, Kathy Sivils4, Kristi Koelsch1, Holly Van Remmen1 and R Hal Scofield5, 1Oklahoma Medical Research Foundation, Oklahoma City, OK, 2University of Oklahoma Health Sciences Center, Edmond, OK, 3University of Washington, Seattle, WA, 4Janssen Research & Development, LLC, Edmond, OK, 5Oklahoma City Veterans Affairs Medical Center, Oklahoma City, OK

    Background/Purpose: Sjögren's disease (SjD) is a chronic, autoimmune condition with diminished lacrimal and salivary gland secretion leading to keratoconjunctivitis sicca and xerostomia, respectively. In addition,…
  • Abstract Number: 0114 • ACR Convergence 2023

    Platelets Are Highly Activated and Could Participate in Immune Abnormality of APS

    Yu Shi1, Xiaofan Luo2, Quan Chen3, Jiuliang zhao4, Mengtao Li4 and xiaofeng Zeng5, 1Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China, 2Nankai University, Tianjin, China, 3Nankai University, Beijing, China, 4Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China, 5Department of Rheumatology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China

    Background/Purpose: Platelets play a pivotal role in the process of coagulation and other biological process. Studies have shown multiple evidences that platelets are highly activated…
  • Abstract Number: 0717 • ACR Convergence 2023

    Mitochondria-mediated Platelet Activation in Polymyalgia Rheumatica

    Despoina Michailidou1, Linda Johansson2, Jorge Armando Gonzalez-Chapa1, Ting Wang1, Junmei Chen3, José A. López3, Solbritt Rantapää-Dahlqvist4 and Christian Lood1, 1University of Washington, Seattle, WA, 2Umea University, Umea, Sweden, 3Bloodworks Research Institute, Seattle, WA, 4Department of Public Health and Clinical Medicine/Rheumatology, Umeå University, Umeå, Sweden

    Background/Purpose: Platelets have been suggested to be involved in polymyalgia rheumatica (PMR) pathogenesis with elevated platelet activation observed in early stages of the disease. Upon…
  • Abstract Number: 0868 • ACR Convergence 2023

    Enhancing Oxidative Phosphorylation Through PDK2 Depletion Alleviates Cartilage Degradation in Surgically Induced Osteoarthritis

    Seungwoo Han1, Jin Han2, Yujung kim2, Yoonhee Kim2 and Donghwi Park3, 1Kyungpook national university hospital, Daegu, South Korea, 2Kyungpook National University, Daegu, South Korea, 3Daegu Fatima hospital, Daegu, South Korea

    Background/Purpose: Although chondrocytes rely primarily on glycolysis to meet their cellular energy needs, they have the metabolic flexibility to shift toward oxidative phosphorylation (OxPhos) in…
  • Abstract Number: 0871 • ACR Convergence 2023

    Mitochondrial Transfer Functionally Restores the Human Osteoarthritis (OA) Chondrocyte, Is Protective Against Oxidative Stress and Improves OA in a Clinical Model of Disease

    Fernando Figueroa1, Angela Court2, Patricia Luz Crawford2, Ana Maria Vega Letter2, Francesca Velarde2, Cynthia Garcia2 and Maroun Khoury2, 1IMPACT, Santiago de Chile, Chile, 2IMPACT, Santiago, Chile

    Background/Purpose: Osteoarthrosis (OA) is a leading cause of pain, disability and early mortality, with no disease modifying treatments. Mitochondrial dysfunction is a known driver of…
  • Abstract Number: 0900 • ACR Convergence 2023

    Complement Deposition on Extracellular Mitochondria Induces Platelet Activation in Vitro

    Marina Barguil Macedo and Christian Lood, University of Washington, Seattle, WA

    Background/Purpose: Mitochondria are extruded upon cell death and platelet activation, being elevated in several inflammatory conditions, including systemic lupus erythematosus (SLE). Mitochondria are immunogenic, with…
  • Abstract Number: 0931 • ACR Convergence 2023

    Down-Regulation of Human NADH-Ubiquinone Oxidoreductase Chain 6 by N6-Methyladenosine Methylation Is Associated with Lupus CD4+ T Cell Activation

    Miheraiy Abdukiyum1, Nan Zhao2, Yuanyuan Zheng1, Tohtihan Alim3, Xiaojun Tang1 and Xuebing Feng2, 1Department of Rheumatology and Immunology, Nanjing Drum Tower Hospital Clinical College, Nanjing University of Chinese Medicine, Nan Jing, China, 2Department of Rheumatology and Immunology, Nanjing Drum Tower Hospital Clinical College, Nanjing University of Chinese Medicine, Nanjing, China, 3Nanjing University, Nanjing, China

    Background/Purpose: Recently mitochondria have been recognized as a key player in the pathogenesis of systemic lupus erythematosus (SLE). Given that N6-methyladenosine (m6A) modifications can regulate…
  • 1
  • 2
  • 3
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology